1-8 of 8
Vincent Laroche
Close
Sort by
Journal Articles

Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study

Andree-Anne Pelland, Xavier Savard, Frederic Barabe, Vincent Laroche, Michaël Munger, Genevieve Gallagher, Nicolas Marcoux, Guy Cantin, Maxime Chénard-Poirier, Robert Delage, Marc Lalancette, Christopher Lemieux
Journal: Blood
Blood (2022) 140 (Supplement 1): 3304–3305.
https://doi.org/10.1182/blood-2022-170223
Published: 2022
Journal Articles

COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry

Mathias Castonguay, Nawar Dakhallah, Marie-Laure Colaiacovo, Camille Jimenez-Cortes, Justin Desroches, Anne-Marie Claveau, Amer Yassine Hafsaoui, Amalia Souza, Pauline Tibout, Anne-Marie Vincent, Veronique Naessens, Josee Brossard, Sharon Abish, Raoul Santiago, Denis Soulieres, Vincent Laroche, Yves D. Pastore, Thai Hoa Tran, Stéphanie Forté
Journal: Blood
Blood (2021) 138 (Supplement 1): 4064.
https://doi.org/10.1182/blood-2021-151361
Published: 2021
Journal Articles

Evaluation of the Role of Plerixafor in Peripheral Blood Progenitor Cell Mobilization and Collection in Autologous Donors with Multiple Myeloma and Non-Hodgkin Lymphoma

Isabelle Blais-Normandin, MD, Philippe Nadeau, PhD, Linda Vallée, Rémy Angers, BSc, Manon Lescault, Nathalie Laflamme, PhD, Narcisse Singbo, Vincent Laroche, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5635.
https://doi.org/10.1182/blood-2019-122511
Published: 2019
Journal Articles

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis

Donald R. Branch, Åsa Hellberg, Christine W. Bruggeman, Jill R. Storry, Darinka Sakac, Megan Blacquiere, Tik Nga Tong, Emeralda Burke-Murphy, Beth Binnington, Nagina Parmar, Lorna Sampson Riden, Kezia Willie, Chantal Armali, Jiwajee Aziz, Lani Lieberman, Vincent Laroche, Jeannie Callum, Yulia Lin, Nadine Shehata, Katerina Pavenski, Wendy Lau, Barbara Hannach, Taco W. Kuijpers, Martin L. Olsson, Christine Cserti-Gazdewich, Jacob Pendergrast
Journal: Blood
Blood (2018) 131 (7): 830–835.
https://doi.org/10.1182/blood-2017-07-796151
Published: 2018
Includes: Supplemental data
Journal Articles

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Christopher Lemieux, MD, Robert Delage, MD, Guy Cantin, MD, Frederic Barabe, MD, Vincent Laroche, MD, Rémy Angers, BSc, Genevieve Gallagher, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5530.
https://doi.org/10.1182/blood.V130.Suppl_1.5530.5530
Published: 2017
Journal Articles

Implementing Cybord As First-Line Therapy For Transplant-Eligible Multiple Myeloma Patients : A Single-Center Preliminary Comparaison

Dominic Duquette, BPharm, MSc, Vincent Laroche, MD, FRCPC
Journal: Blood
Blood (2013) 122 (21): 5403.
https://doi.org/10.1182/blood.V122.21.5403.5403
Published: 2013
Journal Articles

Description Of The Hematological Toxicity Of Different Regimens Using Bortezomib In Multiple Myeloma (CyborD, Vel-Dex and VMP)

Dominic Duquette, BPharm, MSc, Vincent Laroche, MD,FRCPC
Journal: Blood
Blood (2013) 122 (21): 5386.
https://doi.org/10.1182/blood.V122.21.5386.5386
Published: 2013
Journal Articles

The Influence of Bleeding on Trigger Changes for Platelet Transfusion in Chemotherapy-Induced Thrombocytopenic Patients

Benjamin Rioux-Masse, MD, FRCPC, Vincent Laroche, MD, FRCPC, Robert J. Bowman, MD, Bruce R. Lindgren, MS, Claudia S. Cohn, MD, PhD, Shelley M. Pulkrabek, MT(ASCP), CCRC, Terri Carr, RN, BSN, Darin Sumstad, MT(ASCP), Jeffrey McCullough, MD
Journal: Blood
Blood (2011) 118 (21): 1260.
https://doi.org/10.1182/blood.V118.21.1260.1260
Published: 2011